Charles Explorer logo
🇬🇧
Search for publications relevant for "board"

Komentář ke studii

Publication at First Faculty of Medicine |
2022
1 person

This text is not available in the current language. Showing version "cs".Abstract

Komentář ke studii (Pembrolizumab v kombinaci s chemoterapií v léčbě pacientek s triple negativním karcinomem prsu - studie KEYNOTE-355).

Person